In the past, it was believed that quercetin and other flavonoids exerted their effects primarily through their antioxidant properties, such as neutralizing reactive oxygen species (ROS). Today, it is known that compounds in this group also promote vasodilation, help prevent blood clot formation, and inhibit the enzymes responsible for generating ROS.
Quercetin also regulates inflammation by influencing cellular signaling pathways, inhibiting inflammatory enzymes (cyclooxygenases, COX enzymes), and stimulating certain immune cells. These actions reduce measurable inflammatory mediators such as prostaglandins. The effects of quercetin may therefore help restore physiological balance that has been disrupted by disease or even prevent such imbalances from developing. Indeed, in vivo studies have demonstrated beneficial effects of quercetin on cardiovascular disease, various forms of cancer, and metabolic disorders.
- May enhance physical and mental performance
- May reduce the risk of injuries
- May promote muscle growth during high-intensity exercise
What Are the Benefits of Quercetin Supplementation?
Epidemiological studies have demonstrated beneficial associations between flavonoids such as quercetin and a lower risk of cardiovascular disease as well as reduced cardiovascular mortality. A meta-analysis of seven studies involving a total of 587 participants found that quercetin doses exceeding 500 mg per day significantly reduced blood pressure, an important risk factor for cardiovascular disease. Additional systematic reviews of clinical trials confirmed beneficial effects on hypertension and blood lipid profiles when quercetin was taken for more than eight weeks. Even among individuals with normal blood pressure, quercetin supplementation resulted in measurable reductions.
Analyses of preclinical studies have shown that quercetin exerts potent effects against viral respiratory infections by reducing viral load, pro-inflammatory mediators, mucus production, and mortality. Because quercetin inhibits a protease essential for the SARS-CoV-2 virus, researchers have also investigated its potential to suppress coronavirus replication. Initial clinical studies in humans suggest that quercetin may shorten recovery time, reduce the length of hospital stays, and decrease inflammatory markers in the blood.
Quercetin has also shown promise in the fields of diabetes, Alzheimer's disease, and cancer. In animal models, quercetin improved kidney function, reduced diabetes-associated inflammation in the kidneys, and demonstrated neuroprotective effects in Alzheimer's disease. Preclinical studies provide compelling evidence for the anticancer properties of quercetin. However, in many cases, convincing evidence from human clinical trials is still lacking.
In most clinical studies, quercetin was administered at daily doses ranging from 100 mg to 1,000 mg for periods of up to three months. Within this timeframe, it was generally considered safe and well tolerated. Beyond this duration, however, data on long-term safety in humans remain limited. Animal studies suggest that higher doses and prolonged administration may cause liver or kidney toxicity, promote estrogen-dependent cancers, or interfere with the effectiveness of certain medications.
References
Further information and scientific studies on the active ingredient quercetin can be found here.
Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling
www.ncbi.nlm.nih.gov/pmc/articles/PMC3152552
Time-Dependent Protective and Harmful Effects of Quercetin on 6-OHDA-Induced Toxicity in Neuronal SH-SY5Y Cells
www.pubmed.ncbi.nlm.nih.gov/18756631
Comparative Mutagenic Effects of Structurally Similar Flavonoids Quercetin and Taxifolin on Tester Strains Salmonella typhimurium TA102 and Escherichia coli WP-2 uvrA
www.pubmed.ncbi.nlm.nih.gov/19326464
Effect of Quercetin Supplementation on Plasma Lipid Profiles, Blood Pressure, and Glucose Levels: A Systematic Review and Meta-Analysis
www.pubmed.ncbi.nlm.nih.gov/31940027
Quercetin and Endurance Exercise Capacity: A Systematic Review and Meta-Analysis
www.pubmed.ncbi.nlm.nih.gov/21606866
The Effects of Quercetin Supplementation on Blood Pressure: Meta-Analysis
www.pubmed.ncbi.nlm.nih.gov/35948195
Quercetin and Ovarian Cancer: An Evaluation Based on a Systematic Review
www.pubmed.ncbi.nlm.nih.gov/27904580